WEE1 and non-small cell lung carcinoma: High-throughput screening utilizing a siRNA library targeting 719 human kinases identified WEE1 as a modulator of sorafenib response, while AZD1775 was observed to augment the susceptibility of KRAS mutated NSCLC cells towards sorafenib (Caiola et al. 2018).